Cognitive Biotype and Treatment Outcomes at 8 Weeks
REMISSION
The cognitive biotype positive subgroup was distinguished by significantly lower rates of response and remission to antidepressants (HRSD-17 response, 103 of 188 [54.8%] vs 340 of 524 [64.9%]; 